Company · Ownership research

Latigo Biotherapeutics, Inc. LTGO

CIK 0002056611

Form 3 statements with an event date from Nov 1, 2023 to Nov 15, 2026.

Insider tradingInitial holdingsInstitutional holders

Some filings are submitted jointly by several insiders. The SEC form does not apportion the reported figures between them, so results include every joint filer.

Where insider ownership starts.

Form 3 is an initial ownership statement filed when someone becomes a reporting insider. These holdings do not mean they bought shares that day.

202613 of 13 statements

Holdings date	Insider	Initial holdings
Aug 6, 2026	Sanofi 10% owner	2 derivative holdings	▾
Aug 6, 2026	Raidy Kevin Director	No securities reported	▾
Aug 6, 2026	Singla Neil Chief Medical Officer	4 derivative holdings	▾
Aug 6, 2026	Krishnamohan Neha CFO and Chief Business Officer	3 derivative holdings	▾
Aug 6, 2026	Farzan Nima President and CEO · Director	114.45K shares · 4 derivative holdings	▾
Aug 6, 2026	Bonstein Sara Director	1 derivative holding	▾
Aug 6, 2026	Tananbaum James B. Director · 10% owner	7 derivative holdings	▾
Aug 6, 2026	SMITH TODD N Director	No securities reported	▾
Aug 6, 2026	Walbert Timothy P Director	3 derivative holdings	▾
Aug 6, 2026	Schwab Andrew J. · PARMAR KUSH · 5AM Ventures VI, L.P. · 5AM Partners VI, LLC · 5AM Opportunities II, L.P. · 5AM Opportunities II (GP), LLC 10% owner / 10% owner / 10% owner / 10% owner / 10% owner / 10% owner	4 derivative holdings	▾
Aug 6, 2026	SEIDENBERG BETH C Director · 10% owner	3 stock holdings · 7 derivative holdings	▾
Aug 6, 2026	Foresite Capital Fund V, L.P. · Foresite Capital Opportunity Fund V, L.P. · Foresite Capital Management V, LLC · Foresite Capital Opportunity Management V, LLC · Foresite Capital Fund VI LP · Foresite Capital Management VI LLC 10% owner / 10% owner / 10% owner / 10% owner / 10% owner / 10% owner	7 derivative holdings	▾
Aug 6, 2026	Westlake BioPartners Fund I, L.P. · Westlake BioPartners Opportunity GP I, LLC · Westlake BioPartners Opportunity Fund I, L.P. · Westlake BioPartners Fund II, L.P. · Westlake BioPartners GP II, LLC · Westlake BioPartners GP I, LLC 10% owner / 10% owner / 10% owner / 10% owner / 10% owner / 10% owner	3 stock holdings · 7 derivative holdings	▾

Showing 13 / 13 statements in 2026. The complete set is available through the API.

Latigo Biotherapeutics, Inc. · LTGO

Follow the people behind the trades.

Log in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and reach other datasets through the Akkru API.

Download CSV
Earlier filings
Advanced screening & filtering
API & AI access

Already have an account?

＋ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. For 2026, this page lists 13 of 13 statements.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP / CLI.

MCP  https://api.akkrudata.ai/mcp

akkru_initial_holdings
{"action":"list","ticker":"LTGO","page_size":20}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint: https://api.akkrudata.ai/mcp
API / MCP / CLI documentation: /documents
llms.txt: /llms.txt

Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.